Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Schizophrenia

  Free Subscription


03.06.2019

1 Biol Psychiatry
1 Clin Neuropharmacol
2 Mol Psychiatry
2 Psychiatry Res
1 Psychol Med
10 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Biol Psychiatry

  1. PERGOLA G, Di Carlo P, Jaffe AE, Papalino M, et al
    Prefrontal Coexpression of Schizophrenia Risk Genes Is Associated With Treatment Response in Patients.
    Biol Psychiatry. 2019 Apr 3. pii: S0006-3223(19)31152.
    PubMed     Text format     Abstract available


    Clin Neuropharmacol

  2. CHEN WC, Wang HY, Chen PA, Chen IC, et al
    Memantine Rescues Neurosyphilis-Related Schizophrenic-like Features and Cognitive Deficit.
    Clin Neuropharmacol. 2019 May 22. doi: 10.1097/WNF.0000000000000347.
    PubMed     Text format     Abstract available


    Mol Psychiatry

  3. ROSATO M, Stringer S, Gebuis T, Paliukhovich I, et al
    Combined cellomics and proteomics analysis reveals shared neuronal morphology and molecular pathway phenotypes for multiple schizophrenia risk genes.
    Mol Psychiatry. 2019 May 29. pii: 10.1038/s41380-019-0436.
    PubMed     Text format     Abstract available

  4. LESH TA, Maddock RJ, Howell A, Wang H, et al
    Extracellular free water and glutathione in first-episode psychosis-a multimodal investigation of an inflammatory model for psychosis.
    Mol Psychiatry. 2019 May 28. pii: 10.1038/s41380-019-0428.
    PubMed     Text format     Abstract available


    Psychiatry Res

  5. VILLAGONZALO KA, Arnold C, Farhall J, Rossell SL, et al
    Predictors of overall and mental health-related internet use in adults with psychosis.
    Psychiatry Res. 2019;278:12-18.
    PubMed     Text format     Abstract available

  6. GROVER S, R P, Sahoo S, Gopal S, et al
    Relationship of metabolic syndrome and neurocognitive deficits in patients with schizophrenia.
    Psychiatry Res. 2019;278:56-64.
    PubMed     Text format     Abstract available


    Psychol Med

  7. AYONRINDE OA
    Cannabis and psychosis: revisiting a nineteenth century study of 'Indian Hemp and Insanity' in Colonial British India.
    Psychol Med. 2019 May 27:1-9. doi: 10.1017/S0033291719001077.
    PubMed     Text format     Abstract available


    Schizophr Res

  8. STYLA R, Stolarski M, Szymanowska A
    Linking childhood adversities with schizophrenia: A mediating role of the balanced time perspective.
    Schizophr Res. 2019 May 21. pii: S0920-9964(19)30180.
    PubMed     Text format    

  9. MULIYALA KP, Thirthalli J
    Expressed emotions and relapse of psychosis: New vistas for an old concept.
    Schizophr Res. 2019 May 21. pii: S0920-9964(19)30202.
    PubMed     Text format    

  10. COOPER RE, Laxhman N, Crellin N, Moncrieff J, et al
    Psychosocial interventions for people with schizophrenia or psychosis on minimal or no antipsychotic medication: A systematic review.
    Schizophr Res. 2019 May 21. pii: S0920-9964(19)30182.
    PubMed     Text format     Abstract available

  11. SANFRATELLO L, Houck JM, Calhoun VD
    Relationship between MEG global dynamic functional network connectivity measures and symptoms in schizophrenia.
    Schizophr Res. 2019 May 23. pii: S0920-9964(19)30168.
    PubMed     Text format     Abstract available

  12. VAN MIERLO HC, Schot A, Boks MPM, de Witte LD, et al
    The association between schizophrenia and the immune system: Review of the evidence from unbiased 'omic-studies'.
    Schizophr Res. 2019 May 23. pii: S0920-9964(19)30204.
    PubMed     Text format     Abstract available

  13. EATON S, Harrap B, Downey L, Thien K, et al
    Incidence of treated first episode psychosis from an Australian early intervention service and its association with neighbourhood characteristics.
    Schizophr Res. 2019 May 23. pii: S0920-9964(19)30142.
    PubMed     Text format     Abstract available

  14. CHENG YF, Chen VC, Yang YH, Chen KJ, et al
    Risk of schizophrenia among people with obsessive-compulsive disorder: A nationwide population-based cohort study.
    Schizophr Res. 2019 May 24. pii: S0920-9964(19)30185.
    PubMed     Text format     Abstract available

  15. SCHENNACH R, Obermeier M, Spellmann I, Seemuller F, et al
    Remission in schizophrenia - What are we measuring? Comparing the consensus remission criteria to a CGI-based definition of remission and to remission in major depression.
    Schizophr Res. 2019 May 25. pii: S0920-9964(19)30155.
    PubMed     Text format     Abstract available

  16. STEULLET P
    Thalamus-related anomalies as candidate mechanism-based biomarkers for psychosis.
    Schizophr Res. 2019 May 27. pii: S0920-9964(19)30203.
    PubMed     Text format     Abstract available

  17. MAHER S, Ekstrom T, Ongur D, Levy DL, et al
    Functional disconnection between the visual cortex and right fusiform face area in schizophrenia.
    Schizophr Res. 2019 May 21. pii: S0920-9964(19)30177.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: